TG Therapeutics Inc logo

TG Therapeutics Inc

NEW
FRA:NKB2 (USA)   Ordinary Shares
€ 46.7 -1.7 (-3.51%) Jul 29
18.50
P/B:
13.89
Market Cap:
€ 7.19B ($ 8.23B)
Enterprise V:
€ 7.40B ($ 8.47B)
Volume:
21.00
Avg Vol (2M):
457.00
Trade In:

TG Therapeutics Inc Valuation Measures